Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | IT (& TMT) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Life Science |
Investing | United States |
Spindletop Capital is a private equity firm headquartered in Austin, Texas, with a specific focus on the healthcare industry. Founded in 2012, they provide expansion capital and operational expertise to companies within the healthcare and distribution sectors, primarily investing in businesses based in the United States. The firm prides itself on partnering with exceptional leaders to build transformational healthcare companies while emphasizing the importance of alignment of interests with all stakeholders. Spindletop specializes in commercial stage and profitable healthcare companies, offering diversified investment across various healthcare sectors. With a family office heritage, Spindletop Capital highlights the significance of a patient-first approach in the practice of medicine, integrating this core value into interactions with their portfolio companies. They uphold values such as honesty, stewardship, generosity, and determination, aspiring to uphold high standards of integrity and transparency. The firm's strategy revolves around deploying conscious capital for healthcare, serving limited partners with a strong sense of responsibility, and showing determination through the challenges that companies face. The investment team, along with impact and DEI advisors, business advisors, scientific advisors, operations, and finance team, collectively boast over 700 years of experience in the healthcare sector. Spindletop's portfolio demonstrates their commitment to nurturing companies that stand to make significant impacts in healthcare. The firm's heritage ensures an understanding of the time it takes to build market-leading businesses, and they use this insight to provide unrivaled advantages to the entrepreneurs they partner with. Their conscious approach to capital reflects a commitment to do good while achieving financial success, benefiting academic institutions, the community, and patients worldwide.